Macrophage Activation in COVID-19 Patients in Intensive Care Unit
Guylaine Labro(Université de Tours), Khaldoun Kuteifan(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Cyrille Mathien(University of French Guiana), Louise Marie Jandeaux(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Edouard Virot(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Luis Fernando Pinto(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Andreea Rusu(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Valentin Pointurier(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Inès Harzallah(Centre Hospitalier Universitaire de Saint-Étienne), Bernard Drénou(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Agathe Debliquis(Groupe Hospitalier de la Région de Mulhouse et Sud Alsace), Joy Mootien(Centre Hospitalier de Mulhouse)
Cited by 7
Related Papers
Transdifferentiation of hepatocyte‐like cells from the human hepatoma HepaRG cell line through bipotent progenitor†
|Hepatology|2007|352
Discrepancies between Perceptions by Physicians and Nursing Staff of Intensive Care Unit End-of-Life Decisions
|American Journal of Respiratory and Critical Care Medicine|2003|311
Spontaneous-Breathing Trials with Pressure-Support Ventilation or a T-Piece
|New England Journal of Medicine|2022|174
Clinical characteristics and risk factors associated with severe COVID-19: prospective analysis of 1,045 hospitalised cases in North-Eastern France, March 2020
|Eurosurveillance|2020|129
Identification of driver genes for critical forms of COVID-19 in a deeply phenotyped young patient cohort
|Science Translational Medicine|2021|125